In peripheral T-cell lymphoma, FAT1 was frequently mutated and accounted for a significant proportion (39%) of patients, which provided both prognostic and therapeutic implications32. The gene discussed is FAT1; the disease is peripheral T-cell lymphoma, not otherwise specified.